Case Report: When muscle edema is not a myositis flare: Legionella pneumonia complicated by rhabdomyolysis and acute kidney injury in long-standing polymyositis.
Jing Zhang, Lina Zhang, Sheng-Guang Li, Yadan Zou, Ting Long, Ruohan Yu, Yanfeng Zhang, Ji Li
{"title":"Case Report: When muscle edema is not a myositis flare: <i>Legionella</i> pneumonia complicated by rhabdomyolysis and acute kidney injury in long-standing polymyositis.","authors":"Jing Zhang, Lina Zhang, Sheng-Guang Li, Yadan Zou, Ting Long, Ruohan Yu, Yanfeng Zhang, Ji Li","doi":"10.3389/fmed.2026.1952498","DOIUrl":null,"url":null,"abstract":"<p><p><i>Legionella pneumophila</i> is an important cause of severe community-acquired pneumonia and can produce extrapulmonary manifestations that obscure the primary diagnosis. Diagnostic error is especially likely in patients with established idiopathic inflammatory myopathy, because fever, myalgia, weakness, creatine kinase elevation and muscle edema may be attributed to autoimmune flare. We report a 70-year-old woman with a 25-year history of polymyositis receiving long-term corticosteroids and azathioprine who developed high fever, severe bilateral thigh pain and progressive proximal weakness after recent travel. On transfer, she had anuria with bladder distension, dark urine, diffuse posterior-thigh muscle edema, pneumonia, hyponatremia, metabolic acidosis, myoglobinemia and acute kidney injury. <i>Legionella</i> pneumonia with rhabdomyolysis and multifactorial acute kidney injury was suspected clinically, and Legionella-active antimicrobial therapy, hydration, urinary drainage and urine alkalinization were started before microbiological confirmation. A targeted sequencing-based respiratory pathogen assay on sputum collected on Day +4 detected <i>L. pneumophila</i> (145 sequences; estimated concentration <10^3 copies/mL) and respiratory syncytial virus A (266,036 sequences; 10^5 copies/mL), raising the possibility of viral-bacterial coinfection. <i>Legionella</i> urinary antigen, targeted PCR and culture were not documented. After infection and renal injury stabilized, methylprednisolone and intravenous immunoglobulin were used because residual inflammatory myopathy activity remained in the differential. However, creatine kinase and myoglobin had already declined, so subsequent improvement cannot be attributed specifically to immunomodulation. Creatinine fell from 538 μmol/L on Day 0 to 110 μmol/L on Day +9 and 78 μmol/L on Day +30; follow-up chest CT on Day +14 showed marked improvement. This case shows that muscle MRI edema is contextual rather than etiologic. In immunosuppressed myositis patients, pneumonia plus hyponatremia, myoglobinuria and renal injury should prompt early Legionella-active treatment while autoimmune activity is reassessed after infection control.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"13 ","pages":"1952498"},"PeriodicalIF":3.6000,"publicationDate":"2026-10-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13677340/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2026.1952498","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2026/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0
Abstract
Legionella pneumophila is an important cause of severe community-acquired pneumonia and can produce extrapulmonary manifestations that obscure the primary diagnosis. Diagnostic error is especially likely in patients with established idiopathic inflammatory myopathy, because fever, myalgia, weakness, creatine kinase elevation and muscle edema may be attributed to autoimmune flare. We report a 70-year-old woman with a 25-year history of polymyositis receiving long-term corticosteroids and azathioprine who developed high fever, severe bilateral thigh pain and progressive proximal weakness after recent travel. On transfer, she had anuria with bladder distension, dark urine, diffuse posterior-thigh muscle edema, pneumonia, hyponatremia, metabolic acidosis, myoglobinemia and acute kidney injury. Legionella pneumonia with rhabdomyolysis and multifactorial acute kidney injury was suspected clinically, and Legionella-active antimicrobial therapy, hydration, urinary drainage and urine alkalinization were started before microbiological confirmation. A targeted sequencing-based respiratory pathogen assay on sputum collected on Day +4 detected L. pneumophila (145 sequences; estimated concentration <10^3 copies/mL) and respiratory syncytial virus A (266,036 sequences; 10^5 copies/mL), raising the possibility of viral-bacterial coinfection. Legionella urinary antigen, targeted PCR and culture were not documented. After infection and renal injury stabilized, methylprednisolone and intravenous immunoglobulin were used because residual inflammatory myopathy activity remained in the differential. However, creatine kinase and myoglobin had already declined, so subsequent improvement cannot be attributed specifically to immunomodulation. Creatinine fell from 538 μmol/L on Day 0 to 110 μmol/L on Day +9 and 78 μmol/L on Day +30; follow-up chest CT on Day +14 showed marked improvement. This case shows that muscle MRI edema is contextual rather than etiologic. In immunosuppressed myositis patients, pneumonia plus hyponatremia, myoglobinuria and renal injury should prompt early Legionella-active treatment while autoimmune activity is reassessed after infection control.
期刊介绍:
Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide.
In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate
- the use of patient-reported outcomes under real world conditions
- the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines
- the scientific bases for guidelines and decisions from regulatory authorities
- access to medicinal products and medical devices worldwide
- addressing the grand health challenges around the world